ABHP ADVOCACY TO PROTECT 340B DRUG PRICING PROGRAM

The Association of Black Health-system Pharmacists (ABHP) believes: All Americans need access to prescription medications and pharmacist-provided patient care services to help them optimize therapeutic outcomes and reduce the risk of adverse events from medication therapy. The 340B program is essential to covered entities’ ability to advance its direct patient care goals and provide healthcare services to vulnerable patients and communities, including access to medications for the uninsured and underserved patients. Pharmacists are a highly trained and valuable resource. Many are certified and have training in specialty areas such as cardiovascular care, diabetes, and asthma, yet they are currently underutilized. The 340B program allows for strategies to maximize equity and safety of drug distribution and collaborative disease management with physicians while providing patients with access to the full benefit of pharmacist-provided patient care services to achieve better health care. Any efforts to scale back, significantly reduce the benefits of, or expand the regulatory burden of the 340B program, including proposals to dramatically expand reporting requirements on certain 340B hospitals and impose a moratorium on new entrants into the program, are areas we oppose.